Multimodality treatment strategies have changed prognosis of peritoneal metastases

Figure 5 Kaplan-Meier survival curves comparing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy treatment to cytoreductive surgery alone, for gastric peritoneal carcinomatosis[47] (with permission). Kaplan-Meier survival curves comparing CRS-HIPEC treatment to CRS alone, for Gastric PM[47]: This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License, which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. CRS-HIPEC: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy; PM: Peritoneal metastases.